Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Rapid regulation of the photosynthetic light harvesting in the absence of minor antenna and reaction center complexes.

Saccon F, Giovagnetti V, Shukla MK, Ruban AV.

J Exp Bot. 2020 Mar 9. pii: eraa126. doi: 10.1093/jxb/eraa126. [Epub ahead of print]

PMID:
32149343
2.

Preclinical and early systemic lupus erythematosus.

Gatto M, Saccon F, Zen M, Iaccarino L, Doria A.

Best Pract Res Clin Rheumatol. 2019 Aug;33(4):101422. doi: 10.1016/j.berh.2019.06.004. Epub 2019 Jul 12. Review.

PMID:
31810542
3.

Aggregation-Related Nonphotochemical Quenching in the Photosynthetic Membrane.

Chmeliov J, Gelzinis A, Franckevičius M, Tutkus M, Saccon F, Ruban AV, Valkunas L.

J Phys Chem Lett. 2019 Dec 5;10(23):7340-7346. doi: 10.1021/acs.jpclett.9b03100. Epub 2019 Nov 14.

PMID:
31710503
4.

Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.

Zen M, Saccon F, Gatto M, Montesso G, Larosa M, Benvenuti F, Iaccarino L, Doria A.

Rheumatology (Oxford). 2019 Oct 23. pii: kez422. doi: 10.1093/rheumatology/kez422. [Epub ahead of print]

PMID:
31642908
5.

Spectroscopic Properties of Violaxanthin and Lutein Triplet States in LHCII are Independent of Carotenoid Composition.

Saccon F, Durchan M, Kaňa R, Prášil O, Ruban AV, Polívka T.

J Phys Chem B. 2019 Nov 7;123(44):9312-9320. doi: 10.1021/acs.jpcb.9b06293. Epub 2019 Oct 24.

PMID:
31599594
6.

Pulmonary involvement in antisynthetase syndrome.

Gasparotto M, Gatto M, Saccon F, Ghirardello A, Iaccarino L, Doria A.

Curr Opin Rheumatol. 2019 Nov;31(6):603-610. doi: 10.1097/BOR.0000000000000663.

PMID:
31503025
7.

Single-molecule microscopy studies of LHCII enriched in Vio or Zea.

Tutkus M, Saccon F, Chmeliov J, Venckus O, Ciplys I, Ruban AV, Valkunas L.

Biochim Biophys Acta Bioenerg. 2019 Jun 1;1860(6):499-507. doi: 10.1016/j.bbabio.2019.05.002. Epub 2019 May 2.

PMID:
31055058
8.

Diagnostic and prognostic role of renal histopathology in rheumatic diseases.

Saccon F, Gatto M, Larosa M, Ometto F, Felicetti M, Padoan R, Zen M.

Reumatismo. 2018 Oct 3;70(3):165-177. doi: 10.4081/reumatismo.2018.1064. Review.

9.

SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype.

Gatto M, Luisetto R, Ghirardello A, Cavicchioli L, Codolo G, Biasiolo A, Maggioni G, Saccon F, Beggio M, Cappon A, Venturini R, Pontisso P, Doria A.

Front Immunol. 2018 Sep 11;9:2081. doi: 10.3389/fimmu.2018.02081. eCollection 2018.

10.

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Trentin F, Gatto M, Zen M, Larosa M, Nalotto L, Saccon F, Zanatta E, Iaccarino L, Doria A.

Clin Rev Allergy Immunol. 2018 Oct;55(2):237. doi: 10.1007/s12016-018-8704-1.

11.

The causes of altered chlorophyll fluorescence quenching induction in the Arabidopsis mutant lacking all minor antenna complexes.

Townsend AJ, Saccon F, Giovagnetti V, Wilson S, Ungerer P, Ruban AV.

Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):666-675. doi: 10.1016/j.bbabio.2018.03.005. Epub 2018 Mar 13.

12.

Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies.

Trentin F, Gatto M, Zen M, Larosa M, Maddalena L, Nalotto L, Saccon F, Zanatta E, Iaccarino L, Doria A.

Clin Rev Allergy Immunol. 2018 Apr;54(2):331-343. doi: 10.1007/s12016-018-8675-2. Review. Erratum in: Clin Rev Allergy Immunol. 2018 Oct;55(2):237. Maddalena L [corrected to Larosa M ].

13.

Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.

Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.

Ann Rheum Dis. 2018 Jan;77(1):104-110. doi: 10.1136/annrheumdis-2017-211613. Epub 2017 Sep 26.

PMID:
28970217
14.

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.

Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A.

J Autoimmun. 2018 Jan;86:1-8. doi: 10.1016/j.jaut.2017.09.004. Epub 2017 Sep 19.

PMID:
28935492
15.

The effect of different durations of remission on damage accrual: results from a prospective monocentric cohort of Caucasian patients.

Zen M, Iaccarino L, Gatto M, Bettio S, Saccon F, Ghirardello A, Punzi L, Doria A.

Ann Rheum Dis. 2017 Mar;76(3):562-565. doi: 10.1136/annrheumdis-2016-210154. Epub 2016 Nov 24.

PMID:
27884821
16.

Success and failure of biological treatment in systemic lupus erythematosus: A critical analysis.

Gatto M, Saccon F, Zen M, Bettio S, Iaccarino L, Punzi L, Doria A.

J Autoimmun. 2016 Nov;74:94-105. doi: 10.1016/j.jaut.2016.06.014. Epub 2016 Jun 30. Review.

PMID:
27373904
17.

Role of galectin-3 in autoimmune and non-autoimmune nephropathies.

Saccon F, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.

Autoimmun Rev. 2017 Jan;16(1):34-47. doi: 10.1016/j.autrev.2016.09.023. Epub 2016 Sep 23. Review.

PMID:
27666815

Supplemental Content

Loading ...
Support Center